India sets new benchmarks in global leadership
In 2024, transformative advancements positioned India as a global leader in pharmaceuticals, biotechnology, and space exploration.

India solidified its global leadership in 2024, making remarkable strides in pharmaceuticals, biotechnology, defence, nuclear energy, and space exploration. Initiatives like the Production Linked Incentive (PLI) scheme and breakthroughs such as the indigenous antibiotic Nafithromycin propelled the pharmaceutical sector’s exports to USD 28 billion. Biotechnology expanded 13-fold over the past decade, achieving a valuation of USD 130 billion, with ambitions to hit USD 300 billion by 2030.
The nation’s defence sector reached unprecedented levels of self-reliance, recording indigenous production worth 15.24 billion USD and a 30-fold rise in exports. Achievements like the Agni-5 missile test and the deployment of advanced ballistic missile defence systems highlighted India’s strategic capabilities. In nuclear energy, capacity nearly doubled to 8,180 MW, with a roadmap to triple this by 2032 through projects like Bharat Small Reactors.
India’s space programme achieved significant milestones, including the approval of the Venus Orbiter Mission and Chandrayaan-4, as well as advancements in private sector contributions. The foundation of a second spaceport and the celebration of National Space Day underscored the sector’s growing prominence. Additionally, the solar mission Aditya-L1 made groundbreaking contributions to space weather predictions.
Infrastructure and emerging technologies further reinforced India’s position on the global stage. Developments such as the completion of a Hyperloop test track and the GNSS-enabled tolling system showcased futuristic planning. Quantum communication, AI, and blockchain innovations, including the Vishvasya platform, demonstrated India’s commitment to leading the next technological revolution.